Europe Mirna Sequencing And Assay Market Size & Outlook
Europe mirna sequencing and assay market, 2018-2030 (US$M)
Related Markets
Europe mirna sequencing and assay market highlights
- The Europe mirna sequencing and assay market generated a revenue of USD 80.4 million in 2023.
- The market is expected to grow at a CAGR of 13% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 80.4 million |
| Market revenue in 2030 | USD 189.2 million |
| Growth rate | 13% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.4% of the global mirna sequencing and assay market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 227.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MiRNA Sequencing And Assay Market Scope
MiRNA Sequencing And Assay Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe mirna sequencing and assay market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.47% in 2023. Horizon Databook has segmented the Europe mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is highly advanced in terms of technology with presence of a highly skilled workforce in the healthcare and life sciences industries. In addition, supportive governments and increase in funding by the governments & private players in research & development are likely to boost the miRNA sequencing and assay market in Europe.
For instance, European Commission is funding and raising funds for innovative Mirna green Srl that is involved in extracting miRNA from the plant, and it acts as a natural anti-inflammatory, which can further be used to treat non-communicable diseases.
Furthermore, global players are actively involved in developing and offering miRNA sequencing and assay products to strengthen their market position in the European region. For instance, in June 2020, Lexogen GmbH launched the Tra PR (Trans-kingdom, Rapid, Affordable Purification of RISC S) Small RNA Isolation Kit.
Reasons to subscribe to Europe mirna sequencing and assay market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe mirna sequencing and assay market databook
-
Our clientele includes a mix of mirna sequencing and assay market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe mirna sequencing and assay market , including forecasts for subscribers. This continent databook contains high-level insights into Europe mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe mirna sequencing and assay market size, by country, 2018-2030 (US$M)
Europe MiRNA Sequencing And Assay Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
